SLC26A4 Mutations in Korean Population.
10.3342/kjorl-hns.2014.57.11.733
- Author:
Bo Gyung KIM
1
Author Information
1. Department of Otorhinolaryngology-Head and Neck Surgery, Soonchunhyang University College of Medicine, Bucheon, Korea. bgkim@schmc.ac.kr
- Publication Type:Review
- Keywords:
Genotype;
Korean;
Pendrin;
Phenotype;
SLC26A4
- MeSH:
Adenine;
Arginine;
Codon;
Consensus;
Far East;
Frameshift Mutation;
Genetic Association Studies;
Genotype;
Guanine;
Hearing;
Hearing Loss;
Histidine;
Humans;
Introns;
Methionine;
Phenotype;
Tissue Donors;
Valine
- From:Korean Journal of Otolaryngology - Head and Neck Surgery
2014;57(11):733-737
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
SLC26A4 mutations are common cause of congenital hearing loss in East Asia. The carrier frequency of SLC26A4 mutations is 1 in 75 in Korean populations. The SLC26A4 mutation spectrum varies according to the population. The most common mutation in Korean is replacement of histidine by arginine at codon 723 followed by exchange of guanine for adenine at the consensus acceptor splice site of intron 7, adenine to guanine change at position +3 transition donor splice site of intron 9, methionine to valine at position 147, and frameshift mutation by insertion T at N-terminal 2. Recent studies analyzed the genotype-phenotype correlation of SLC26A4 mutation and suggested that surface expression ratio of pendrin and residual anion exchange activity was related to the genotype of SLC26A4 mutations. The targeted drug to Korean SLC26A4 mutations would be helpful in preserving hearing in patients with SLC26A4 mutations.
